This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Thursday's Early Winners & Losers

PXRE Group (PXT) shot up more than 12% in extended trading Wednesday as the Bermuda-based reinsurance company announced it will merge with insurance underwriter Argonaut (AGII - Get Report). The planned stock swap will create a new company called Argo Group International, of which roughly 27% will be owned by former PXRE shareholders. Former Argonaut holders will own the rest.

PXRE separately reported narrowing losses on plummeting revenue in the fourth quarter. Its shares were surging 55 cents to $5.01 in recent after-hours action. Argonaut stock was up 35 cents, or 1%, to $34.50.

PDI (PDII - Get Report) shares jumped after the business-services firm swung to a fourth-quarter profit of $4.8 million, or 35 cents a share, compared with a year-ago loss of 83 cents a share. The Saddle River, N.J., company's revenue sank 29% year over year to $55.8 million, but this beats two analysts' estimates by $7.2 million, according to Thomson Financial. Shares were trading up $1.63, or 16.5%, to $11.50.

Spectranetics (SPNC - Get Report) gained on strong preliminary results from a study of its Turbo-Booster device, which is proposed to help treat blockages in the main artery above the knee. The Food and Drug Administration decided, jointly with Spectranetics, that the study should end early in order that it be submitted for regulatory review. The trial had begun in July. Shares of the Colorado-based company were climbing 62 cents, or 6.3%, to $10.50, in recent after-hours trading.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
AGII $49.59 0.00%
HIBB $49.49 -0.54%
PDII $1.36 -2.90%
SPNC $35.00 -1.80%
WAVX $0.69 2.10%


DOW 17,863.70 -112.61 -0.63%
S&P 500 2,075.53 -10.71 -0.51%
NASDAQ 4,920.1210 -27.32 -0.55%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs